Study to Evaluate the Effect of HT-4253 for the Prevention of Alzheimer's Disease in APOE4 Carriers
Clinical trial NCT07399171 · RECRUITING
Trial details
- NCT number
- NCT07399171
- Sponsor
- Halia Therapeutics, Inc.
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-05-12
- Primary completion
- 2028-02-01
- Enrollment
- 112
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.